All Episodes
Displaying 1 - 20 of 44 in total
Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan
A mother’s search for answers to her daughter’s relentless brain tumor led her into natural killer cell biology, cancer immunotherapy, and biotech entrepreneurship.Spo...
The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi
Oncology drug development is becoming more complex, and bioanalysis can no longer be treated as simple drug measurement.Sponsored by Leucentra, https://leucentra.com/I...
Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker
Can artificial intelligence help make cancer therapies safer, more targeted, and more effective?In this episode of BioTalk Unzipped, Gregory Austin sits down with Dr. ...
Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains
Why haven’t we cured cancer yet? A Genentech scientist explains the real reason.In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with ...
The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney
Recorded October 31, 2025In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Kate Neville, immunologist turned seasoned biotech ...
Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins
In this episode of BioTalk Unzipped, hosts Gregory Austin and Dr. Chad Briscoe sit down with Glafabra CEO: Dr. Chris Hopkins, geneticist, biochemist, and biotech entre...
Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva
In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Binodh DeSilva, Senior Vice President of Bioanalysis at Ultragenyx Pharmaceu...
Unlocking Antibody Development with AI with Dr. Pin-Kuang Lai
In this episode of BioTalk Unzipped, hosts Gregory Austin and Dr. Chad Briscoe interview Asst. Professor Pin-Kuang Lai from Stevens Institute of Technology about his k...
The Science and Hope of Brain Cancer with Dr. Robert Thorne, Denali Therapeutics
In this powerful episode (#35) of BioTalk Unzipped, recorded live at the AAPS NBC conference in Boston, Gregory Austin engages in a deep conversation with a leading Ne...
Inside AAPS NBC with AAPS President Dr. Russ Weiner
In this special episode (#34) of BioTalk Unzipped, recorded live at the AAPS NBC conference in Boston, Gregory Austin and Dr. Chad Briscoe sit down with AAPS President...
Building Successful Life Science Companies with Katrina Rogers
In this powerful episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Katrina Rogers, a 25-year life sciences veteran, biotech equity advocat...
Navigating Challenges in Drug Discovery with Dr. Alfred Botchway
In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Alfred Botchway, CEO of Attentive Science, to discuss his journey in biomedi...
2024 Year In Review: BioTalk Unzipped
In this episode of BioTalk Unzipped, hosts Gregory Austin and Dr. Chad Briscoe reflect on their journey over the past year, discussing key themes and insights gained f...
Women in Pharmaceutical Sciences and their Allies with Dr. Ines Santos and Dr. Julie Sable
In this episode of BioTalk Unzipped, hosts Gregory Austin and Chad Briscoe welcome Dr. Ines Santos and Dr. Julia Sable to discuss their experiences and contributions i...
Can AI Become Your Doctor? FDA Regulation, Medical Devices & the Future of Healthcare
Could artificial intelligence become your doctor someday? In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Alex Friedman, a r...
The Future of Dosing: Pharmacometrics, Oncology & Virtual Trials with Dr. Nathan Teuscher
In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe continue their conversation with Dr. Nathan Teuscher, a clinical pharmacology and pharmacometr...
The Future of Pharmacometrics with Dr. Nathan Teuscher
In this episode of BioTalk Unzipped, hosts Gregory Austin and Chad Briscoe welcome Dr. Nathan Teuscher, a seasoned expert in clinical pharmacology and pharmacometrics....
Will FDA’s New LDT Rule Slow Drug Development? with Dr. Mark Arnold
In this episode of BioTalk Unzipped, host Gregory Austin and co-host Chad Briscoe engage with Dr. Mark Arnold, a distinguished bioanalytical thought leader. They discu...
Digital Twins: The Future of Drug Discovery with Dr. Tomáš Helikar
BioTalk Unzipped, hosts Gregory Austin and Chad Briscoe engage with Dr. Tomas Helikar in an exciting discussion on the future of AI, digital twins, and personalized me...
Transforming Immunology: The Promise of Digital Twins with Dr. Tomáš Helikar
Dr. Tomas Helikar, a leading researcher in bioinformatics and systems biology, delves into groundbreaking work on developing a personalized immune digital twin, which ...
